Royal Bank of Canada
DVAX

Royal Bank of Canada’s Dynavax Technologies DVAX Stock Holding History

Royal Bank of Canada’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,414
Closed -$145K – 7256
2025
Q4 		$145K Buy
9,414
+1,855
+25% +$20.4K ﹤0.01% 4984
2025
Q3 		$76K Sell
7,559
-9,113
-55% -$94.9K ﹤0.01% 5644
2025
Q2 		$165K Buy
16,672
+413
+3% +$4.35K ﹤0.01% 5293
2025
Q1 		$211K Sell
16,259
-832
-5% -$11K ﹤0.01% 4662
2024
Q4 		$219K Sell
17,091
-4,666
-21% -$56.4K ﹤0.01% 4746
2024
Q3 		$243K Buy
21,757
+857
+4% +$9.45K ﹤0.01% 4656
2024
Q2 		$234K Buy
20,900
+6,639
+47% +$77.3K ﹤0.01% 4633
2024
Q1 		$177K Sell
14,261
-32,547
-70% -$425K ﹤0.01% 4794
2023
Q4 		$654K Buy
46,808
+14,708
+46% +$204K ﹤0.01% 4029
2023
Q3 		$474K Buy
32,100
+6,349
+25% +$89.3K ﹤0.01% 4076
2023
Q2 		$332K Buy
25,751
+7,392
+40% +$84.2K ﹤0.01% 4281
2023
Q1 		$181K Sell
18,359
-12,456
-40% -$133K ﹤0.01% 4716
2022
Q4 		$329K Buy
30,815
+15,344
+99% +$178K ﹤0.01% 4456
2022
Q3 		$161K Sell
15,471
-16,353
-51% -$213K ﹤0.01% 4948
2022
Q2 		$400K Sell
31,824
-5,732
-15% -$60.9K ﹤0.01% 4265
2022
Q1 		$408K Sell
37,556
-1,801
-5% -$21.9K ﹤0.01% 4430
2021
Q4 		$554K Buy
39,357
+3,330
+9% +$54.8K ﹤0.01% 4359
2021
Q3 		$692K Buy
36,027
+17,775
+97% +$236K ﹤0.01% 4061
2021
Q2 		$180K Buy
18,252
+401
+2% +$3.65K ﹤0.01% 5164
2021
Q1 		$175K Buy
17,851
+241
+1% +$1.99K ﹤0.01% 5054
2020
Q4 		$79K Sell
17,610
-18,835
-52% -$85.3K ﹤0.01% 5455
2020
Q3 		$157K Buy
36,445
+1,043
+3% +$7.44K ﹤0.01% 4704
2020
Q2 		$314K Sell
35,402
-93,569
-73% -$473K ﹤0.01% 4128
2020
Q1 		$455K Buy
128,971
+9,274
+8% +$43K ﹤0.01% 3702
2019
Q4 		$685K Buy
119,697
+41,920
+54% +$224K ﹤0.01% 3748
2019
Q3 		$278K Buy
77,777
+67,275
+641% +$261K ﹤0.01% 4237
2019
Q2 		$42K Sell
10,502
-8,269
-44% -$47.9K ﹤0.01% 5355
2019
Q1 		$137K Buy
18,771
+503
+3% +$4.92K ﹤0.01% 4575
2018
Q4 		$168K Buy
18,268
+281
+2% +$3.11K ﹤0.01% 4452
2018
Q3 		$224K Buy
17,987
+601
+3% +$8.13K ﹤0.01% 4407
2018
Q2 		$265K Sell
17,386
-490
-3% -$8.47K ﹤0.01% 4241
2018
Q1 		$355K Sell
17,876
-852
-5% -$14.7K ﹤0.01% 3942
2017
Q4 		$350K Sell
18,728
-4,949
-21% -$99.4K ﹤0.01% 4049
2017
Q3 		$510K Buy
23,677
+3,223
+16% +$51K ﹤0.01% 3780
2017
Q2 		$198K Buy
20,454
+2,975
+17% +$19.3K ﹤0.01% 4366
2017
Q1 		$104K Sell
17,479
-1,091
-6% -$5.25K ﹤0.01% 4738
2016
Q4 		$73K Sell
18,570
-901
-5% -$6.6K ﹤0.01% 5041
2016
Q3 		$204K Hold
19,471
– – ﹤0.01% 4420
2016
Q2 		$284K Buy
19,471
+363
+2% +$6.2K ﹤0.01% 4148
2016
Q1 		$367K Sell
19,108
-9,784
-34% -$198K ﹤0.01% 3904
2015
Q4 		$698K Buy
28,892
+19,901
+221% +$499K ﹤0.01% 3451
2015
Q3 		$221K Buy
8,991
+8,521
+1,813% +$241K ﹤0.01% 4239
2015
Q2 		$11K Sell
470
-100
-18% -$2.18K ﹤0.01% 6002
2015
Q1 		$12K Buy
570
+100
+21% +$1.92K ﹤0.01% 5513
2014
Q4 		$8K Hold
470
– – ﹤0.01% 5670
2014
Q3 		$7K Buy
470
+200
+74% +$2.88K ﹤0.01% 5568
2014
Q2 		$4K Hold
270
– – ﹤0.01% 5606
2014
Q1 		$5K Hold
270
– – ﹤0.01% 5565
2013
Q4 		$5K Buy
+270
New +$3.95K ﹤0.01% 5596

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's DVAX Position: Q1 2026 in Review

Royal Bank of Canada sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 9,414 shares — an estimated $145K sold.

Royal Bank of Canada first reported a position in DVAX in Q4 2013 and held it in 49 quarters. The position peaked at $698K in Q4 2015. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Royal Bank of Canada reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 9,414 Dynavax Technologies shares in Q1 2026, an estimated $145K.
  • Royal Bank of Canada first reported a position in Dynavax Technologies in Q4 2013 and held it in 49 quarters.
  • Royal Bank of Canada's Dynavax Technologies position peaked at $698K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.